TASIGNA
Live / Registered — Registered — Section 71 accepted (as of 28 Mar 2019)
What this means for you
Registered since 09 Jun 2009. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Jun 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79062925
- Registration number
- 3635627
- Mark type
- Word mark
- Filed
- 07 Aug 2008
- Published for opposition
- 24 Mar 2009
- Registered
- 09 Jun 2009
- Next maintenance filing
- §71 ten-year affidavit of use, due by 09 Jun 2029 (grace period to 09 Dec 2029)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology
Owner
- Novartis AG, Basel, CH
- Novartis AG, CH
- Novartis AG, CH
Prior registrations
Prosecution history
- 25 Apr 2024 — INTERNATIONAL REGISTRATION RENEWED
- 28 Mar 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 28 Mar 2019 — REGISTERED-SEC.71 ACCEPTED
- 19 Mar 2019 — TEAS SECTION 71 RECEIVED
- 09 Jun 2018 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 11 Jun 2015 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 11 Jun 2015 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 11 Jun 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 May 2015 — TEAS SECTION 71 & 15 RECEIVED
- 18 Sept 2014 — INTERNATIONAL REGISTRATION RENEWED
- 12 Apr 2013 — NEW REPRESENTATIVE AT IB RECEIVED
- 23 Feb 2013 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 11 Dec 2009 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Sept 2009 — FINAL DISPOSITION NOTICE SENT TO IB
- 22 Sept 2009 — FINAL DISPOSITION PROCESSED